ADVANCED MALIGNANCIES
Clinical trials for ADVANCED MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANCIES trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Terminated trial tests Triple-Threat attack on tough cancers
Disease control TerminatedThis study tested whether combining three different cancer drugs was safe and could help control advanced solid tumors that had stopped responding to other treatments. It involved 70 people with cancers like advanced lung cancer and colorectal cancer. The goal was to see if this …
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New cancer drug enters first human tests
Disease control TerminatedThis was an early-stage study to test the safety and find the right dose of a new drug called BR105 in adults with advanced cancers that have not responded to standard treatments. Researchers gave the drug by IV infusion and closely monitored patients for side effects over 21 day…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC